» Articles » PMID: 37103078

Abnormal Hyperphosphorylation of Tau in Canine Immune-mediated Meningoencephalitis

Overview
Journal In Vivo
Specialty Oncology
Date 2023 Apr 27
PMID 37103078
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Tau is a microtubule-associated protein involved in the assembly and stabilization of microtubules. In human medicine, hyperphosphorylation of tau is associated with microtubule instability and is considered to play a role in the progression of multiple sclerosis (MS). MS is an autoimmune neurological disease that shares many characteristics, including pathological mechanisms, with canine meningoencephalitis of unknown etiology (MUE). With this background, this study investigated the presence of hyperphosphorylated tau in dogs with MUE and experimental autoimmune encephalomyelitis (EAE).

Materials And Methods: In total, eight brain samples were examined from two neurologically normal dogs, three dogs with MUE, and three canine EAE models. Anti-(phospho-S396) tau antibody was used for immunohisto-chemistry, which stained hyperphosphorylated tau.

Results: In normal brain tissues, hyperphosphorylated tau was not found. In all the dogs with EAE and one of the dogs with MUE, immunoreactivity for S396 p-tau was observed in glial cell cytoplasm and the background in the periphery of the inflammatory lesion.

Conclusion: These results suggest for the first time that tau pathology may be involved in the progression of neuroinflammation in dogs, similar to that in human MS.

References
1.
Park E, Uchida K, Nakayama H . Comprehensive immunohistochemical studies on canine necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME). Vet Pathol. 2012; 49(4):682-92. DOI: 10.1177/0300985811429311. View

2.
Kuharik M, Edwards M, Farlow M, Becker G, Azzarelli B, KLATTE E . Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions. AJNR Am J Neuroradiol. 1988; 9(4):643-8. PMC: 8332017. View

3.
Islas-Hernandez A, Aguilar-Talamantes H, Bertado-Cortes B, Mejia-delCastillo G, Carrera-Pineda R, Cuevas-Garcia C . BDNF and Tau as biomarkers of severity in multiple sclerosis. Biomark Med. 2018; 12(7):717-726. DOI: 10.2217/bmm-2017-0374. View

4.
Popescu B, Pirko I, Lucchinetti C . Pathology of multiple sclerosis: where do we stand?. Continuum (Minneap Minn). 2013; 19(4 Multiple Sclerosis):901-21. PMC: 3915566. DOI: 10.1212/01.CON.0000433291.23091.65. View

5.
Shriver L, Dittel B . T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Am J Pathol. 2006; 169(3):999-1011. PMC: 1698821. DOI: 10.2353/ajpath.2006.050791. View